Literature DB >> 3031791

Neurosarcoidosis. A report of ten patients illustrating some usual and unusual manifestations.

O P Sharma, A Anders.   

Abstract

The common and not so common neurologic lesions due to sarcoidosis include cranial nerve palsies, meningitis, hypothalamic and pituitary lesions, basilar meningitis, polyneuropathy, space occupying lesions and spinal cord involvement. The diagnosis of neurosarcoidosis requires a compatible clinical or radiologic picture of sarcoidosis and histological confirmation of noncaseating granulomas. Serum ACE, Gallium-67 lung scan and bronchoalveolar lavage are of help in supporting the diagnosis and establishing activity of the disease. A CT scan with enhancement is the diagnostic procedure of choice. Corticosteroids are the cornerstone of therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3031791

Source DB:  PubMed          Journal:  Sarcoidosis        ISSN: 0393-1447


  5 in total

Review 1.  Sarcoidosis presenting with an acute Guillain-Barré syndrome.

Authors:  R Miller; N Sheron; S Semple
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

Review 2.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

3.  A case of neurosarcoidosis that presented with symptoms of Guillain-Barré syndrome.

Authors:  A Oldroyd; T Dawson; J Nixon
Journal:  BMJ Case Rep       Date:  2011-04-01

Review 4.  Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

Authors:  Merav Lidar; Amir Dori; Yair Levy; Zvi Lidar; Joab Chapman; Pnina Langevitz
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Hypothalamic-pituitary sarcoidosis with hypopituitarism. Long-term remission with methylprednisolone pulse therapy.

Authors:  Ana Molina; Juan Mañá; Carles Villabona; Miguel Fernández-Castañer; Juan Soler
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.